Clinical Trials

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, announced that it has dosed the first patient in a Phase 2 study evaluating its lead therapeutic candidate, ATYR1923,...

TrialSpark, a tech-enabled drug development company committed to improving the speed, quality, and innovation of clinical trials, announced the launch of Project Covalence, a turnkey trial platform that enables investigators and sponsors to rapidly launch clinical trials for COVID-19....

Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19. The investigational medicine, referred to as JS016, is being co-developed by Junshi...

Sun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19. The Company received approval from the Drugs Controller General of India (DCGI) for conducting Phase...

Junshi Biosciences , a China-based biopharmaceutical company specializing in discovery, development and commercialization of novel therapies, and Merck, a world leading science and technology company, announced their collaboration on a clinical trial program designed to investigate the efficacy and...

Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19. This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly...

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as...